Investigator's choice of treatment clinical trials

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

This study compares a drug called acalabrutinib with other standard treatments for people with chronic leukaemia and heart problems. It aims to see how safe and well acalabrutinib works in this group, particularly focusing on its effects on the heart.